We are pleased to announce that our NGS panels now include CNV analysis.
In addition, three new genes have been added to the Bardet-Biedl Syndrome panel.
Visit www.asperbio.com/asper-ophthalmics to learn more about our new testing options and see the updated price list.
NGS panel for Ectopia Lentis is now available. Visit www.asperbio.com/ectopia-lentis to read more.
A new article on Lynch syndrome mutations shared by the Baltic States has been released with the participation of Asper Biotech’s researchers. The study supports the idea that populations from neighboring countries can share genetic alterations in MMR genes as 20% of families from Estonia, Latvia and Lithuania with known MMR pathogenic changes carry mutation detected previously in Poland.
For the original article published by Clinical Genetics: Lynch syndrome mutations shared by the Baltic States and Poland
Asper Biotech will participate at International Symposium on Usher Syndrome and Related Diseases, on 27-29th of May 2010 in Valencia, Spain.
Asper Biotech’s genetic counsellor Ilona Lind will present the report on Asper’s diagnostic tool for the Usher syndrome.
The goal is to offer the country’s eye doctors and other specialists the wide portfolio of Asper’s test. Currently working in close collaboration with Optovision Ltd. Asper Biotech has the goal of reaching the Hungarian eye doctors offering them diagnostics solutions that are enhanced by our partner’s advancing knowledge in eye disease genetics. Co-operation with internet medicine network and wide partner network enables to reach the goals quickly and efficiently bringing on stronger brand presence for Asper and a comprehensive medical product market for Optovision.
Optovision is widening its network of clinics and doctors over all medical areas that Asper’s tests cover.
Several new innovative genetic tests and services will be launched on the market this year. At the European Human Genetics Conference on 12-15 June 2010 in Gothenburg, Sweden Asper’s representatives will provide wider and more attractive products than ever before. We are glad to meet our partners and clients in Asper Biotech (#B218) and Genorama (#B134) boxes.
The prize of German Economy was established to bring into focus Estonian – German economical cooperation and to promote companies with the best experiences in this area. From 16 qualified companies and 5 finalists Asper Biotech was highlighted as the most innovative, as well as carrying most social value together with German scientific partners from well-known German Universities as Tübingen, Regensburg, Köln, Bonn, Bremen University, Humbolt University of Berlin, Bayer Julius-Mazimilians University, Charite Institut and many others. Continue reading The Champions of innovation
Asper Biotech participated at Central European Forum of Biotechnology & Innovative Bioeconomy BIOFORUM on 3-4th of June in Lodz, Poland. Asper was represented in booth #37 in collaboration with Tartu Biotechnology Park. Asper also participated at 9th Annual International Geneforum on 12-13th of June in Tartu, Estonia. The exhibition stand at Geneforum has been co-financed by the European Union Regional Development Fund.
Continue reading Asper Biotech at BIOFORUM and Geneforum
Asper Biotech participated at European Association for Vision and Eye Research (EVER) held in Portoroz, Slovenia on September 30 – October 3, 2009.